Practice Guideline

. 2021 Aug;37(8):1260-1262.

doi: 10.1016/j.cjca.2021.05.011. Epub 2021 Jun 6.

Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team

Ian Paterson¹, Krishnan Ramanathan², Rakesh Aurora³, David Bewick⁴, Chi-Ming Chow⁵, Brian Clarke⁶, Simone Cowan², Anique Ducharme⁷, Kenneth Gin², Michelle Graham⁸, Anil Gupta⁹, Davinder S Jassal¹⁰, Mustapha Kazmi⁶, Andrew Krahn², Yoan Lamarche¹¹, Ariane Marelli¹², Idan Roifman¹³, Marc Ruel¹⁴, Gurmeet Singh⁸, Larry Sterns¹⁵, Ricky Turgeon¹⁶, Sean Virani², Kenny K Wong¹⁷, Shelley Zieroth¹⁸

Affiliations

¹ Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada.
² Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada.
³ Section of Cardiac Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
⁴ Saint John Regional Hospital, Saint John, New Brunswick, Canada.
⁵ Department of Medicine, University of Toronto, Division of Cardiology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
⁶ Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
⁷ Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.
⁸ Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
⁹ Trillium Health Partners, Mississauga, Ontario, Canada.
¹⁰ St Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
¹¹ Department of Surgery, Institut de cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada.
¹² McGill University Health Centre, Montreal, Quebec, Canada.
¹³ Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
¹⁴ University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
¹⁵ Royal Jubilee Hospital, Victoria, British Columbia, Canada.
¹⁶ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
¹⁷ IWK Health, Dalhousie University, Halifax, Nova Scotia, Canada.
¹⁸ Cardiac Sciences Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: szieroth@sbgh.mb.ca.

PMID: 34090980
PMCID: PMC8180343
DOI: 10.1016/j.cjca.2021.05.011

Practice Guideline

Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team

Ian Paterson et al. Can J Cardiol. 2021 Aug.

. 2021 Aug;37(8):1260-1262.

doi: 10.1016/j.cjca.2021.05.011. Epub 2021 Jun 6.

Authors

Affiliations

¹ Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada.
² Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada.
³ Section of Cardiac Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
⁴ Saint John Regional Hospital, Saint John, New Brunswick, Canada.
⁵ Department of Medicine, University of Toronto, Division of Cardiology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
⁶ Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
⁷ Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada.
⁸ Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
⁹ Trillium Health Partners, Mississauga, Ontario, Canada.
¹⁰ St Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
¹¹ Department of Surgery, Institut de cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada.
¹² McGill University Health Centre, Montreal, Quebec, Canada.
¹³ Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
¹⁴ University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
¹⁵ Royal Jubilee Hospital, Victoria, British Columbia, Canada.
¹⁶ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
¹⁷ IWK Health, Dalhousie University, Halifax, Nova Scotia, Canada.
¹⁸ Cardiac Sciences Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: szieroth@sbgh.mb.ca.

PMID: 34090980
PMCID: PMC8180343
DOI: 10.1016/j.cjca.2021.05.011

Abstract
in English, French

It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, "long COVID-19" is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19.

Il est désormais largement reconnu que la COVID-19 peut être associée à d'importantes limitations physiques à moyen terme et, potentiellement, à plus long terme. Le terme « COVID-19 longue » est utilisé pour décrire tout patient présentant des symptômes persistants après une infection aiguë par le virus de la COVID-19 (soit au-delà de quatre semaines). On suppose qu'une atteinte cardiaque pourrait être liée aux symptômes qui persistent après la disparition de l'infection aiguë, dans le cadre de ce syndrome. Le Groupe de travail sur la réaction rapide à la COVID-19 de la Société canadienne de cardiologie a produit le présent document afin de fournir des conseils aux professionnels de la santé sur la prise en charge optimale des patients chez qui l'on soupçonne des complications cardiaques causées par la COVID-19 longue.

PubMed Disclaimer

Figures

**Figure 1**
Long COVID-19 patient care map.

See this image and copyright information in PMC

References

1. Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C. Incidence of myocardial injury in COVID-19-infected patients: a systematic review and meta-analysis. Diseases. 2020;8:40. - PMC - PubMed
1. Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020;9:665–677. - PMC - PubMed
1. Kawakami R, Sakamoto A, Kawai K. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77:314–325. - PMC - PubMed
1. Puntmann VO, Carerj ML, Wieters I. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265–1273. - PMC - PubMed
1. Kotecha T, Knight DS, Razvi Y. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42:1866–1878. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team

Affiliations

Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team

Authors

Affiliations

Abstract
in English, French

Figures

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract in English, French

Figures

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Abstract
in English, French